TY - JOUR
T1 - RORγt represses IL-10 production in Th17 cells to maintain their pathogenicity in inducing intestinal inflammation
AU - Sun, Mingming
AU - He, Chong
AU - Chen, Liang
AU - Yang, Wenjing
AU - Wu, Wei
AU - Chen, Feidi
AU - Cao, Anthony T.
AU - Yao, Suxia
AU - Dann, Sara M.
AU - Dhar, T. G.Murali
AU - Salter-Cid, Luisa
AU - Zhao, Qihong
AU - Liu, Zhanju
AU - Cong, Yingzi
N1 - Publisher Copyright:
© 2018 by The American Association of Immunologists, Inc.
PY - 2019/1/1
Y1 - 2019/1/1
N2 - The role of retinoid-related orphan receptor γ t (RORγt) in Th17 cell differentiation has been well established; however, how it regulates other T cell lineages is still not clearly understood. In this study, we report that in mice, while promoting Th17 cell differentiation, RORγt inhibited IL-10 production by T cells, thereby preserving the pathogenicity of Th17 cells. Treatment with RORγt-specific inhibitor suppressed Th17 cell signature cytokines, but promoted IL-10 production. RORγt inhibitor-treated Th17 cells induce less severe colitis compared with control Th17 cells. Mechanistically, the RORγt inhibitor induced T cell expression of Blimp-1 (encoded by Prdm1). Prdm1-/- T cells produced significantly fewer IL-10 when treated with RORγt inhibitor compared with wild-type T cells. Furthermore, RORγt inhibitor-treated Prdm1-/- Th17 cells induce more severe colitis compared with RORγt inhibitor-treated wild-type Th17 cells. Collectively, our studies reveal a novel mechanism by which RORγt drives and maintains pathogenic Th17 cell development by inhibiting IL-10 production.
AB - The role of retinoid-related orphan receptor γ t (RORγt) in Th17 cell differentiation has been well established; however, how it regulates other T cell lineages is still not clearly understood. In this study, we report that in mice, while promoting Th17 cell differentiation, RORγt inhibited IL-10 production by T cells, thereby preserving the pathogenicity of Th17 cells. Treatment with RORγt-specific inhibitor suppressed Th17 cell signature cytokines, but promoted IL-10 production. RORγt inhibitor-treated Th17 cells induce less severe colitis compared with control Th17 cells. Mechanistically, the RORγt inhibitor induced T cell expression of Blimp-1 (encoded by Prdm1). Prdm1-/- T cells produced significantly fewer IL-10 when treated with RORγt inhibitor compared with wild-type T cells. Furthermore, RORγt inhibitor-treated Prdm1-/- Th17 cells induce more severe colitis compared with RORγt inhibitor-treated wild-type Th17 cells. Collectively, our studies reveal a novel mechanism by which RORγt drives and maintains pathogenic Th17 cell development by inhibiting IL-10 production.
UR - http://www.scopus.com/inward/record.url?scp=85059236194&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059236194&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1701697
DO - 10.4049/jimmunol.1701697
M3 - Article
C2 - 30478092
AN - SCOPUS:85059236194
SN - 0022-1767
VL - 202
SP - 79
EP - 92
JO - Journal of Immunology
JF - Journal of Immunology
IS - 1
ER -